Search
for
Sort by
Research 241–270 of 1000+
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Recently Identified Forms of Epidermolysis Bullosa
- Immunofluorescent localization of collagen types I, III and IV, fibronectin, laminin, and basement membrane proteoglycan in developing mouse skin
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- Basement membrane changes in lichen planopilaris
- Alopecia areata in a composite tissue (hand) allograft recipient following graft rejection
- Expression of Plectin-1 and Trichohyalin in Human Tongue Cancer Cells
- Epidermolysis bullosa simplex: a paradigm for disorders of tissue fragility
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Stem Cell Therapies for Epidermolysis Bullosa Treatment
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Does Complement Have a Role in the Pathogenesis of Alopecia Areata?
- ZALCITABINE
- Generalized atrophic benign epidermolysis bullosa.
- Mutations in KLHL24 Add to the Molecular Heterogeneity of Epidermolysis Bullosa Simplex
- Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
- Radiation-induced alopecia
- Prophylaxis and Management of Skin Toxicities
- Characterization of the epidermal-dermal junction in hiPSC-derived skin organoids
- Phenotypic modulation of human hair matrix cells (trichocytes) by environmental influence in vitro and in vivo.
- Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
- Focal palmoplantar callosities in non-Herlitz junctional epidermolysis bullosa
- Friend or foe: A systematic review of dupilumab and alopecia areata
- Folliculotropic Mycosis Fungoides with Skewed T-cell Receptor CDR3 Motif: Suggestive of Lipid-antigen Selection?
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Addressing the average lifespan of skin diseases is critical to good patient care
- The Immunological Intersection of Psoriasis and Autoimmune Diseases: Shared Pathways and Clinical Implications
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- 74126 GLP-1RA Medications and Alopecia: Evaluating Risk Across Diabetic and Non-Diabetic Populations